Identifying predictors of placebo response in osteoarthritis clinical trials of three agents with different routes of delivery: A meta-analysis using individual patient data
Joanne Stocks(University of Nottingham), Weiya Zhang(University of Nottingham), David A. Walsh(Arthritis UK), Michael Doherty(University of Nottingham), Marienke van Middelkoop(Erasmus MC), Monica S M Persson(Swedish Rheumatism Association), T.E. McAlindon(University of Massachusetts Chan Medical School), J. Runhaar(Erasmus MC), R. Lambert(University of Alberta), Allen D. Sawitzke(University of Utah), Mohammad Hashem Hashempur(Shiraz University of Medical Sciences), Ismaël Atchia(Newcastle University), Sita Bierma‐Zeinstra(Erasmus MC)
Cited by 1
Related Papers
OARSI guidelines for the non-surgical management of knee osteoarthritis
|Osteoarthritis and Cartilage|2014|3.1k
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
|Annals of the Rheumatic Diseases|2013|1.4k
OARSI recommendations for the management of hip and knee osteoarthritis, Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence
|Osteoarthritis and Cartilage|2007|800
Toward understanding and exploiting tumor heterogeneity
|Nature Medicine|2015|770
Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study
|Annals of the Rheumatic Diseases|2014|620